228 related articles for article (PubMed ID: 10849757)
21. Different cysteine proteinases involved in bone resorption and osteoclast formation.
Brage M; Abrahamson M; Lindström V; Grubb A; Lerner UH
Calcif Tissue Int; 2005 Jun; 76(6):439-47. PubMed ID: 15906014
[TBL] [Abstract][Full Text] [Related]
22. Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma.
Hansen T; Unger RE; Gaumann A; Hundorf I; Maurer J; Kirkpatrick CJ; Kriegsmann J
Mod Pathol; 2001 Dec; 14(12):1226-31. PubMed ID: 11743044
[TBL] [Abstract][Full Text] [Related]
23. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.
Wilson SR; Peters C; Saftig P; Brömme D
J Biol Chem; 2009 Jan; 284(4):2584-92. PubMed ID: 19028686
[TBL] [Abstract][Full Text] [Related]
24. Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts.
Everts V; Hou WS; Rialland X; Tigchelaar W; Saftig P; Brömme D; Gelb BD; Beertsen W
Calcif Tissue Int; 2003 Oct; 73(4):380-6. PubMed ID: 12874701
[TBL] [Abstract][Full Text] [Related]
25. Quantification of the expression levels of lysosomal cysteine proteinases in purified human osteoclastic cells by competitive RT-PCR.
Ishibashi O; Inui T; Mori Y; Kurokawa T; Kokubo T; Kumegawa M
Calcif Tissue Int; 2001 Feb; 68(2):109-16. PubMed ID: 11310346
[TBL] [Abstract][Full Text] [Related]
26. Advances in osteoclast biology resulting from the study of osteopetrotic mutations.
Segovia-Silvestre T; Neutzsky-Wulff AV; Sorensen MG; Christiansen C; Bollerslev J; Karsdal MA; Henriksen K
Hum Genet; 2009 Jan; 124(6):561-77. PubMed ID: 18987890
[TBL] [Abstract][Full Text] [Related]
27. Human osteopetrosis and other sclerosing disorders: recent genetic developments.
de Vernejoul MC; Bénichou O
Calcif Tissue Int; 2001 Jul; 69(1):1-6. PubMed ID: 11685426
[TBL] [Abstract][Full Text] [Related]
28. A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeys.
Kumar S; Dare L; Vasko-Moser JA; James IE; Blake SM; Rickard DJ; Hwang SM; Tomaszek T; Yamashita DS; Marquis RW; Oh H; Jeong JU; Veber DF; Gowen M; Lark MW; Stroup G
Bone; 2007 Jan; 40(1):122-31. PubMed ID: 16962401
[TBL] [Abstract][Full Text] [Related]
29. The mouse osteopetrotic grey-lethal mutation induces a defect in osteoclast maturation/function.
Rajapurohitam V; Chalhoub N; Benachenhou N; Neff L; Baron R; Vacher J
Bone; 2001 May; 28(5):513-23. PubMed ID: 11344051
[TBL] [Abstract][Full Text] [Related]
30. Altered hematopoietic stem cell and osteoclast precursor frequency in cathepsin K null mice.
Jacome-Galarza C; Soung do Y; Adapala NS; Pickarski M; Sanjay A; Duong LT; Lorenzo JA; Drissi H
J Cell Biochem; 2014 Aug; 115(8):1449-57. PubMed ID: 24590570
[TBL] [Abstract][Full Text] [Related]
31. Cathepsin K: a therapeutic target for bone diseases.
Zhao Q; Jia Y; Xiao Y
Biochem Biophys Res Commun; 2009 Mar; 380(4):721-3. PubMed ID: 19338743
[TBL] [Abstract][Full Text] [Related]
32. Calvarial osteoclasts express a higher level of tartrate-resistant acid phosphatase than long bone osteoclasts and activation does not depend on cathepsin K or L activity.
Perez-Amodio S; Jansen DC; Schoenmaker T; Vogels IM; Reinheckel T; Hayman AR; Cox TM; Saftig P; Beertsen W; Everts V
Calcif Tissue Int; 2006 Oct; 79(4):245-54. PubMed ID: 17033726
[TBL] [Abstract][Full Text] [Related]
33. Determination of bone markers in pycnodysostosis: effects of cathepsin K deficiency on bone matrix degradation.
Nishi Y; Atley L; Eyre DE; Edelson JG; Superti-Furga A; Yasuda T; Desnick RJ; Gelb BD
J Bone Miner Res; 1999 Nov; 14(11):1902-8. PubMed ID: 10571690
[TBL] [Abstract][Full Text] [Related]
34. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones.
Xia L; Kilb J; Wex H; Li Z; Lipyansky A; Breuil V; Stein L; Palmer JT; Dempster DW; Brömme D
Biol Chem; 1999 Jun; 380(6):679-87. PubMed ID: 10430032
[TBL] [Abstract][Full Text] [Related]
35. Degradation of the organic phase of bone by osteoclasts: a secondary role for lysosomal acidification.
Henriksen K; Sørensen MG; Nielsen RH; Gram J; Schaller S; Dziegiel MH; Everts V; Bollerslev J; Karsdal MA
J Bone Miner Res; 2006 Jan; 21(1):58-66. PubMed ID: 16355274
[TBL] [Abstract][Full Text] [Related]
36. Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosis.
Fratzl-Zelman N; Valenta A; Roschger P; Nader A; Gelb BD; Fratzl P; Klaushofer K
J Clin Endocrinol Metab; 2004 Apr; 89(4):1538-47. PubMed ID: 15070910
[TBL] [Abstract][Full Text] [Related]
37. Localisation and activity of cathepsins K and B in equine osteoclasts.
Gray AW; Davies ME; Jeffcott LB
Res Vet Sci; 2002 Apr; 72(2):95-103. PubMed ID: 12027589
[TBL] [Abstract][Full Text] [Related]
38. Overexpression of cathepsin K accelerates the resorption cycle and osteoblast differentiation in vitro.
Morko J; Kiviranta R; Mulari MT; Ivaska KK; Väänänen HK; Vuorio E; Laitala-Leinonen T
Bone; 2009 Apr; 44(4):717-28. PubMed ID: 19118660
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities.
Delaissé JM; Andersen TL; Engsig MT; Henriksen K; Troen T; Blavier L
Microsc Res Tech; 2003 Aug; 61(6):504-13. PubMed ID: 12879418
[TBL] [Abstract][Full Text] [Related]
40. Mutations of CTSK result in pycnodysostosis via a reduction in cathepsin K protein.
Ho N; Punturieri A; Wilkin D; Szabo J; Johnson M; Whaley J; Davis J; Clark A; Weiss S; Francomano C
J Bone Miner Res; 1999 Oct; 14(10):1649-53. PubMed ID: 10491211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
